Clinical trials
Recruiting Diabetes Mellitus, Type 1 trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2019 | 1 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 6 |
| 2025 | 8 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 24 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Second Xiangya Hospital of Central South University | 9 |
| Children's Hospital of Fudan University | 2 |
| Nanjing Medical University | 2 |
| Peking University First Hospital | 2 |
| The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2 |
| EndoCell Therapeutics, Inc. | 1 |
| Hangzhou Reprogenix Bioscience, Inc | 1 |
| Sanofi | 1 |
| Shanghai Zhongshan Hospital | 1 |
| The Second Hospital of Nanjing Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 1 | 24 |
| Diabetes Mellitus | 3 |
| Hypoglycemia | 2 |
| Autoimmune Diseases | 1 |
| Cognitive Dysfunction | 1 |
| Genetic Risk Score | 1 |
| Immunologic Deficiency Syndromes | 1 |
| Insulin Resistance | 1 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.